http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104984341-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104984341-B |
| titleOfInvention | A kind of preparation method of the composite Nano preparation of near-infrared laser triggering |
| abstract | The present invention relates to the preparation method of the composite Nano preparation of near-infrared laser triggering, the nanometer formulation is irradiated using near-infrared 980nm laser, photosensitive micella release medicine is triggered by the transmitting light of wherein upper conversion nano grain, reach the purpose of diagnoses and treatment, solve visible ray penetration capacity poor, the problem of diagnoses and treatment secondary medication, deep tissues are irradiated using near infrared light 980nm laser, make C 60 Produce active oxygen, it is to avoid ultraviolet light causes the damage that the drug release of micella rupture of membranes is caused to tissue, the treatment to tumour is more accurate, safety, effectively, composite Nano preparation prepared by the present invention can be under near infrared light 980nm irradiations, timing positioning release medicine, while can make C 60 Produce active oxygen in deeper tissue, collaboration chemotherapy kills tumour cell, with reference to fluorescence imaging and magnetic resonance imaging, realize diagnoses and treatment integration, it is to avoid the problem of secondary medication, raw material sources enrich, and cost is low, and using effect is good. |
| priorityDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.